Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa, each possessing a 5-enolpyruvylshikimate 3-phosphate synthase that is sensitive to inhibition by glyphosate [N-(phosphonomethyl)glycitie], provide a good cross-section of organisms exemplifying the biochemical diversity of the aromatic pathway targeted by this potent antimicrobial compound. The pattern of growth inhibition, the alteration in levels of aromatic-pathway enzynies, and the accumulation of early-pathway metabolites after the addition of glyphosate were distinctive for each organism. Substantial intracellular shikimate-3-phosphate accumulated in response to glyphosate treatment in all three organisms. Both E. coli and P. aeruginosa, but not B. subtilis, accumulated near-millimolar levels of shikimate-3-phosphate in the culture medium. Intracellular backup of commonpathway precursors of shikimate-3-phosphate was substantial in B. subtilis, moderate in P. aeruginosa, and not detectable in E. coli. The full complement of aromatic amino acids prevented growth inhibition and metabolite accumulation in E. coli and P. aeruginosa where amino acid end products directly control early-pathway enzyme activity. In contrast, the initial prevention of growth inhibition in the presence of aromatic amino acids in B. subtilis was succeeded by progressively greater growth inhibition that correlated with rapid metabolite accumulation. In B. subtilis glyphosate can decrease prephenate concentrations sufficiently to uncouple the sequentially acting loops of feedback inhibition that ordinarily link end product excess to feedback inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase by prephenate. The consequential unrestrained entry of energy-rich substrates into the aromatic pathway, even in the presence of aromatic amino acid end products, is an energy drain that potentially accounts for the inability of end products to fully reverse glyphosate inhibition in B. subtilis. Even in E. coi, after glyphosate inhibition and metabolite accumulation were allowed to become fully established, a transient period where end products were capable of only partial reversal of growth inhibition occurred. The distinctive metabolism produced by dissimilation of different carbon sources also produced profound effects upon glyphosate sensitivity.
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Many antimetabolites that act against biosynthetic pathways mimic end products, causing inappropriate regulatory effects upon enzymes having early-pathway positions. In contrast, N-(phosphonomethyl)glycine (PMG), an herbicide known as glyphosate, is an exceedingly effective inhibitor of a mid-pathway enzyme of aromatic amino acid biosynthesis, 5-enolpyruvylshikimate 3-phosphate (EPSP) synthase. EPSP synthase has been shown to be a sensitive target of PMG action in procaryotes, lower eucaryotes, and higher plants (see reference 34 for reference citations). Although PMG is now under intensive study in higher plants by virtue of its potent herbicidal properties, antimicrobial studies are few. The presence of PMG during growth can produce massive accumulation of shikimate-3-phosphate behind the blocked EPSP synthase (Fig. 1) , an effect caused by decreased levels of end product molecules that normally feedback inhibit or repress the initial enzyme of the pathway, 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase.
Three molecular events triggered by PMG could account in part for growth inhibition: (i) starvation for aromatic amino acids, (ii) an energy drain imposed by utilization of one phosphoenolpyruvate (PEP) molecule and one ATP molecule for every molecule of shikimate-3-phosphate accu-mulated, and (iii) the possible toxicity of accumulated common-pathway intermediates, particularly phosphorylated compounds such as DAHP or shikimate-3-phosphate. In this study side-by-side comparisons have been made of Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis to evaluate the energy drain effects of PMG in organisms exhibiting diversity of aromatic-pathway construction and regulation.
In an organism such as E. coli, the administration of aromatic amino acids would be expected to reverse the action of PMG completely, regardless of which effects listed above contribute to growth inhibition. This follows because the three aromatic amino acids act directly as feedback inhibitors and repression signals for the three regulatory isozymes of DAHP synthase in E. coli (7) (Fig. 1) . Although P. aeruginosa differs substantially from E. coli in the enzymic construction and overall regulation of the aromatic amino acid pathway (1, 20) , complete reversal of PMG inhibition of growth by aromatic amino acids is also expected in P. aeruginosa because the two DAHP synthase isozymes present (Fig. 1) are directly controlled by Ltyrosine and L-tryptophan (39) .
Expectations are markedly different for B. subtilis, an organism in which end products control DAHP synthase by an indirect mechanism, employing a sequentially acting network of allosteric enzymes (23, 30) . DAHP synthase of B. subtilis is feedback inhibited by chorismate and prephenate ( Fig. 1 reflect overall end product levels. In this study we pursue the question whether PMG (through prevention of chorismate and prephenate formation in B. subtilis) has the potential to uncouple the normal control of DAHP synthase by aromatic amino acid end products.
MATERIALS AND METHODS Microorganisms. All bacterial strains used were wild-type prototrophs. E. coli K-12 EMG2 (3, 13) was obtained from B. Bachmann of the E. coli Genetic Stock Center, Department of Human Genetics, Yale University School of Medicine, New Haven, Conn. P. aeruginosa PAO1 (19) and B. subtilis 168 strain NP1 (27) were from the culture collection of our laboratory.
Growth of bacteria and culture conditions. E. coli was grown in M9 minimal medium (29) subtilis. Exponentially growing cultures were used to inoculate either 20 ml (for E. coli and B. subtilis) or 10 ml (for P. aeruginosa) of fresh mnedium containing supplements as indicated. These cultures were grown in 125-ml sidearm flasks with vigorous shaking at 37°C.
Extracts were prepared from 1,000-mnl cultures contained in 2,800-ml Fernbach flasks which were shaken at 300 rpm at 37°C. Cultures in the late-exponential phase of growth were harvested by centrifugation, washed twice with cold 50 mM potassium phosphate buffer (pH 7.0), and stored as whole cell pellets at -20°C.
Preparation of crude extracts. Extracts for DAHP synthase determinations were prepared in 50 mM potassium phosphate buffer (pH 7.0) containing either 1 mM MgCl2 and 100 mM KCl for B. subtilis or 1 mM dithiothreitol for E. coli. All EPSP synthase activities were determined from extracts prepared in 25 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 7.5 at 37°C). The pH of the HEPES buffer was adjusted with tetramethylammonium hydroxide to avoid the introduction of cations. The extract from E. coli to be used for anthranilate synthase determinations was prepared in 10 mM Tris hydrochloride buffer (pH 7.8 at 25°C) containing 10 mM MgCl2 and 10 mM 2-mercaptoethanol. Extracts from B. subtilis to be used for anthranilate synthase assays were prepared in the buffer described by Kane et al. (25) , except that 20 mM L-glutamine was added to the extract buffer. The extracts for determining prephenate dehydrogenase activities were prepared in 100 mM Tris hydrochloride buffer (pH 8.5 at 25°C) containing 50 mM KCl plus 0.5 mM dithiothreitol.
Cell pellets, suspended in 3 to 5 ml of the required buffer, were disrupted by either ultrasound or lysozyme. For E. coli and P. aeruginosa, cells were disrupted at 4°C with three 20 25 ,ug/ml was added to degrade DNA. The disrupted cell suspensions were ultracentrifuged at 145,000 x g for 60 min at 4°C to remove cell debris. With the exception of the extracts used for assay of EPSP synthase from B. subtilis and P. aeruginosa, the resulting supernatants were then desalted by passage over a Sephadex G-25 column (PD-10; Pharmacia Fine Chemicals, Uppsala, Sweden). The B. subtilis and P. aeruginosa extracts used for EPSP synthase assays were extensively dialyzed against 25 mM HEPES buffer (adjusted to pH 7.5 as described above) to ensure removal of potential activating cations.
Analytical procedures. Protein concentrations were estimated by the method of Bradford (5) as described in Bio-Rad technical bulletin 1051 (Bio-Rad Laboratories, Richmond, Calif.). DAHP synthase was assayed by the method of Srinivasan and Sprinson (37) as modified by Jensen and Nester (24) . Reaction mixtures for the B. subtilis enzyme were prepared as described by Jensen and Nester (24) , but were modified for E. coli to contain 50 mM potassium phosphate buffer (pH 7.0) containing 1 mM dithiothreitol, 1 mM PEP, 1 mM D-erythrose-4-phosphate, and 1 mM MgSO4. Anthranilate synthase from B. subtilis was assayed by the method of Kane and Jensen (26) , whereas anthranilate synthase from E. coli was assayed as described by Calhoun et al. (11) . EPSP synthase was assayed by following the disappearance of PEP (17) as modified by Rubin et al. (34) , except that standard reaction mixtures contained 3 mM PEP, 3 mM shikimate-3-phosphate, 25 mM HEPES buffer (pH 7.5 at 37°C), and the necessary activating cation as designated below. Prephenate dehydrogenase was assayed as described by Champney and Jensen (12) for B. subtilis, whereas the method of Byng et al. (9) was used for E. coli.
Determination of metabolite levels. For quantitation of intracellular metabolites, whole cell pellets were washed twice with 50 mM potassium phosphate buffer (pH 7.0), resuspended in the buffer, and disrupted by sonication (four 30-s bursts at 100 W). Cell debris was removed from the extract by ultracentrifugation at 145,000 x g for 60 min at 4°C. The protein concentration of each extract was then determined, and accumulated DAHP was quantitated by the method of Jensen and Nester (23) . To determine intracellular levels of shikimate and shikimate-3-phosphate, samples of each extract were heated in a 100°C water bath for 2 min, centrifuged at 12,000 x g for 10 min, and passed through a 0.2-p,m polycarbonate membrane (Nuclepore Corp., Pleasanton, Calif.) to remove most of the protein, nucleic acid, and particulates. Shikimate and shikimate-3-phosphate levels were determined in these preparations by using highperformance liquid chromatography. Samples were injected into a 20-,ul loop and eluted from a Baker Amino column (4.6 by 250 mm, 5-jxm particle size) (J.T. Baker Chemical Co., Phillipsburg, N.J.) with a mobile phase consisting of acetonitrile-H20-phosphoric acid (95:4:1) at a flow rate of 1.0 ml/min. Shikimate and shikimate-3-phosphate were detected at 215 nm and quantitated using a standard curve generated from the recorded peak heights obtained with authentic shikimate and shikimate-3-phosphate.
Extracellular shikimate and shikimate-3-phosphate levels were determined directly from the cell-free media after harvesting. A sample of each medium was passed through a 0.4-ram polycarbonate membrane (Nuclepore) before processing as described above for measuring intracellular accumulation.
Biochemicals and chemicals. Unless indicated otherwise, all biochemicals and commercially prepared enzymes were obtained from Sigma Chemical Co., St. Louis, Mo. Analytical-grade PMG (99.9% pure) was a gift from Monsanto Co., St. Louis, Mo. Shikimate-3-phosphate was prepared as previously described (28) , except that it was converted to a tetramethylammonium salt instead of the conventional sodium or potassium salt. Barium prephenate was prepared from culture supernatants of a tyrosine auxotroph of Salmonella typhimurium (14) and was converted to the potassium salt with a twofold excess of K204 before use. Chorismate was prepared from culture supernatants of Klebsiella pneumoniae by the method of Gibson (16) . Acetonitrile and phosphoric acid for high-performance liquid chromatography and the standard reagent-grade chemicals were obtained from Fisher Scientific Co., Springfield, N.J.
RESULTS
Inhibition of growth by PMG. PMG was capable of exerting effective antimetabolite action against all three microorganisms under study. Figure 2 illustrates the family of growth curves generated in E. ccli in the presence of PMG concentrations ranging between 0.5 and 15 mM. Care was taken to ensure that experiments were started with exponentially dividing cell populations. Reports of initial growth lags after the addition of PMG (2, 32) Once the stable rate of inhibited growth characteristic of any given concentration of PMG was achieved, it endured for at least 24 h. The inset of Fig. 2 shows a replot in which the doubling time eventually achieved is plotted against PMG concentration. About 2 mM PMG was required to inhibit the growth rate of E. ccli by 50%.
The family of growth curves generated in B. subtilis in the presence of PMG is shown in Fig. 3 . An initial phase of progressively increasing inhibition similar to that seen in E.
coli was observed, although the time required for transition to a stable rate of inhibited growth appeared to be shorter, e.g., no longer than 4 h at the highest PMG concentration used. Although the concentration of PMG required (about 1.8 mM) to produce 50% inhibition was similar to that seen in E. coli, the responsivity of B. subtilis to PMG is compressed within a smaller concentration range than in E. coli. This is shown by the sigmoid inhibition curve plotted in the inset of Fig. 3 . On fructose-based medium the family of growth-inhibition curves generated for P. aeruginosa was similar to those obtained with E. coli and B. subtilis on glucose-based medium (Fig. 4) . Relative to the doubling time on fructosebased medium, the duration of the period of progressively Effect of PMG upon aromatic-pathway enzyme levels. Except for the enzymes of the tryptophan pathway (11), aromatic-pathway enzymes (and indeed biosynthetic-pathway enzymes in general) of P. aeruginosa appear not to exhibit repression-derepression behavior in response to end product levels. Since aromatic amino acid biosynthesis is subject to repression control in both B. subtilis and E. coli, a number of enzymes were assayed after growth in the presence and absence of PMG (Table 2) . In E. coli the derepression of DAHP synthase undoubtedly reflects the selective elevation of DAHP synthase-Tyr, an isozyme that is largely repressed in minimal medium (22) . EPSP synthase of E. coli has been reported to be constitutive (38) . Prephenate dehydrogenase activity in E. coli was increased almost ninefold after growth in PMG, whereas anthranilate synthase exhibited only modest derepression compared with its potential level during maximal derepression.
DAHP synthase, EPSP synthase, and prephenate dehydrogenase activities of B. subtilis (grown in the presence of PMG) were all found to be at levels that were close to maximal derepression (31) . Interestingly, anthranilate synthase was repressed more than 60% in the presence of 2 mM PMG. Since chorismate mutase inevitably elevates with DAHP synthase in strain 168 of B. subtilis by virture of both being shared catalytic activities of a bifunctional protein (7) , the results indicate that when chorismate levels are lowered by PMG action against EPSP synthase, anthranilate synthase can still maintain a competitive advantage over chorismate mutase-even with an eight-to ninefold decrease in the ratio of anthranilate synthase to chorismate mutase. This indicates the relatively better ability of B. subtilis anthranilate synthase to compete with chorismate mutase at low levels of chorismate, compared with E. coli.
Reversal of PMG inhibition by aromatic amino acids. The data shown in Fig. 5 are consistent with the evidence cited above for superior ability of the tryptophan pathway to scavenge limited intracellular chorismate in B. subtilis compared to E. coli. The inhibition of growth of E. coli established in the presence of PMG for 2 h was almost completely reversed by the combination of all three aromatic amino acids (Fig. SA) . The addition of L-phenylalanine plus Ltyrosine, however, led to only partial reversal of growth inhibition (40% inhibition remaining), indicating that tryptophan synthesis must be rate limiting to growth.
In contrast, the combination of L-phenylalanine and Ltyrosine was as effective as all three aromatic amino acids in reversing PMG-inhibited growth of B. subtilis (Fig. 5B) . Presumably, still higher concentrations of PMG causing more than the 92% inhibition of growth observed in this experiment would be required to demonstrate tryptophan limitation in the presence of L-phenylalanine and L-tyrosine. Table 3 shows a comparison of the abilities of all possible combinations of aromatic amino acids to reverse growth inhibition by PMG in B. subtilis and E. coli. A striking difference between E. coli and B. subtilis was that in B. subtilis, established PMG inhibition of growth (92%) was not completely reversed by aromatic amino acids. A residual inhibition of about 45% persisted under these conditions ( Fig. SB and Table 3 ). The possibility was considered that in B. subtilis the normal regulation of DAHP synthase might become uncoupled from proper responsivity to end product levels in the presence of PMG. In B. subtilis end products regulate DAHP synthase indirectly via their effect upon intracellular levels of prephenate (23, 30) . In contrast, end product supply in E. coli directly regulates the DAHP synthase isozymes. Thus, the inhibition of growth that persists in the presence of all three aromatic amino acids (Fig. SB) reflects the consequences of massive drain of energy (and possibly of reducing power) within the shikimate pathway of B. subtilis.
The latter idea predicts that accumulation of commonpathway intermediates would be observed in B. subtilis during growth on sufficiently high concentrations of PMG, even if aromatic amino acids were supplied simultaneously. In E. coli and P. aeruginosa, on the other hand, effective early-pathway control by end products ought to prevent any accumulation of common-pathway intermediates in the presence of even high concentrations of PMG. These expectations were fully realized ( results in only a partial ability of aromatic amino acids to reverse growth inhibition. Such residual inhibition not reversed by aromatic amino acids is transient, however, and full reversal becomes established after restoration of early pathway control and relief of the energy burden. In B. subtilis and other microbes (8) having a pattern of indirect control over DAHP synthase (sequential feedback inhibition), aromatic amino acids can only prevent growth inhibition by PMG for a short initial period that is succeeded by progressively greater inhibition. At sufficiently high PMG concentrations, aromatic amino acid supplementation can only partially reverse PMG inhibition of growth, and residual inhibition endures indefinitely.
It is quite possible that supplementation with nonaromatic metabolites that spare the need for energy-rich compounds will prove to reverse residual inhibition of growth in the presence of aromatic amino acids. If so, all systems may prove to be fully reversible, given the appropriate nutritional regimen.
B. subtilis as a model for plant systems. In higher plants a chloroplast-localized DAtiP synthase exists that is feedback inhibited by L-arogenate, thtis constituting another variation of sequential feedback inhibition (35; R. J. Ganson, T. A. d'Amato, and R. A. Jensen, Plant Physiol., in press). The inhibition of plant cell culture systems by PMG is characteristically reversed orily partially by aromatic amino acids, and it has been hypothesized that energy drain within the chloroplast compartment plays a significant role in the herbicidal mechanism of PMG action (21, 33) . The analogous pattern of early pathway regulation in B. subtilis makes it ideal as a model for examination of the impact of energy drain effects upon metabolic pathways of higher plants.
The variety of prevention and reversal results obtained with yeast (4), algae (18) , plants (18) , photosynthetic eucaryotes (10), and bacteria (2, 18, 32) suggests that the patterns of reversal of PMG inhibition observed in individual organisms may indeed reflect the diversity of aromatic amino acid biosynthesis in nature (8) .
PMG as a physiological probe. PMG can be used as a tool to manipulate wild-type cultures for derepression. For example, tryptophan-pathway enzymes can be derepressed in E. coli by growth of PMG-treated cultures in the presence of L-phenylalanine plus L-tyrosine. In P. aeruginosa growth in the presence of 100 mM PMG in glucose-based medium results in limitation of the tryptophan pathway. In contrast, the tryptophan-pathway enzymes in B. subtilis actually become repressed during partial inhibition of growth in the presence of PMG. The latter result indicates that under conditions of precursor limitation, anthranilate synthase of (25, 27) .
